Cargando…

Negative Conversion of Progesterone Receptor Status after Primary Systemic Therapy Is Associated with Poor Clinical Outcome in Patients with Breast Cancer

PURPOSE: Alteration of biomarker status after primary systemic therapy (PST) is occasionally found in breast cancer. This study was conducted to clarify the clinical implications of change of biomarker status in breast cancer patients treated with PST. MATERIALS AND METHODS: The pre-chemotherapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ahn, Soomin, Kim, Hyun Jeong, Kim, Milim, Chung, Yul Ri, Kang, Eunyoung, Kim, Eun-Kyu, Kim, Se Hyun, Kim, Yu Jung, Kim, Jee Hyun, Kim, In Ah, Park, So Yeon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Cancer Association 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192918/ https://www.ncbi.nlm.nih.gov/pubmed/29361816 http://dx.doi.org/10.4143/crt.2017.552

Ejemplares similares

Changes in Biomarker Status in Metastatic Breast Cancer and Their Prognostic Value
por: Woo, Ji Won, et al.
Publicado: (2019)

Microinvasive Carcinoma versus Ductal Carcinoma In Situ: A Comparison of Clinicopathological Features and Clinical Outcomes
por: Kim, Milim, et al.
Publicado: (2018)

Clinical implications of changes in the diversity of c-MYC copy number variation after neoadjuvant chemotherapy in breast cancer
por: Chung, Yul Ri, et al.
Publicado: (2018)

Genomic profiling of multiple breast cancer reveals inter-lesional heterogeneity
por: Ahn, Soomin, et al.
Publicado: (2020)

Immune microenvironment in ductal carcinoma in situ: a comparison with invasive carcinoma of the breast
por: Kim, Milim, et al.
Publicado: (2020)

Prognostic implications of regression of metastatic axillary lymph nodes after neoadjuvant chemotherapy in patients with breast cancer
por: Chung, Yul Ri, et al.
Publicado: (2021)

Cytologic Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features and Its Impact on the Risk of Malignancy in the Bethesda System for Reporting Thyroid Cytopathology: An Institutional Experience
por: Kim, Milim, et al.
Publicado: (2018)

Changes and prognostic values of tumor-infiltrating lymphocyte subsets after primary systemic therapy in breast cancer
por: Ahn, Soomin, et al.
Publicado: (2020)

Prognostic significance of S100A8-positive immune cells in relation to other immune cell infiltration in pre-invasive and invasive breast cancers
por: Woo, Ji Won, et al.
Publicado: (2020)

Mammary Carcinoma Arising in Microglandular Adenosis: A Report of Five Cases
por: Kim, Mimi, et al.
Publicado: (2017)

Benign Intraductal Papilloma without Atypia on Core Needle Biopsy Has a Low Rate of Upgrading to Malignancy after Excision
por: Han, Song-Hee, et al.
Publicado: (2018)

Clinical Application of Next-Generation Sequencing in Patients With Breast Cancer: Real-World Data
por: Suh, Koung Jin, et al.
Publicado: (2022)

Expression of embryonal stem cell transcription factors in breast cancer: Oct4 as an indicator for poor clinical outcome and tamoxifen resistance
por: Gwak, Jae Moon, et al.
Publicado: (2017)

A Novel Prognostic Nomogram for Predicting Risks of Distant Failure in Patients with Invasive Breast Cancer Following Postoperative Adjuvant Radiotherapy
por: Lim, Yu Jin, et al.
Publicado: (2018)

Role of CXCL10 in the progression of in situ to invasive carcinoma of the breast
por: Kim, Milim, et al.
Publicado: (2021)

Contralateral Breast Cancer and Ipsilateral Breast Tumor Recurrence in BRCA1/2 Carriers and Non-Carriers at High-Risk of Hereditary Breast Cancer
por: Yoon, Kyung-Hwak, et al.
Publicado: (2019)

Expression of HLA class I is associated with immune cell infiltration and patient outcome in breast cancer
por: Han, Song-Hee, et al.
Publicado: (2022)

FGFR1 is amplified during the progression of in situ to invasive breast carcinoma
por: Jang, Min Hye, et al.
Publicado: (2012)

Effect of Estrogen Receptor Expression Level and Hormonal Therapy on Prognosis of Early Breast Cancer
por: Yoon, Kyung-Hwak, et al.
Publicado: (2022)

Triple negativity and young age as prognostic factors in lymph node-negative invasive ductal carcinoma of 1 cm or less
por: Kwon, Ji Hyun, et al.
Publicado: (2010)

Diagnostic Assessment of Deep Learning Algorithms for Frozen Tissue Section Analysis in Women with Breast Cancer
por: Kim, Young-Gon, et al.
Publicado: (2023)

Efficacy of dual progesterone administration (intramuscular and vaginal) for luteal support in fresh day 3 or day 4 embryo transfer cycles
por: Nho, Eun Jee, et al.
Publicado: (2020)

Male metaplastic breast cancer with poor prognosis: A case report
por: Kim, Hyun Yul, et al.
Publicado: (2022)

Development and External Validation of a Machine Learning Model to Predict Pathological Complete Response After Neoadjuvant Chemotherapy in Breast Cancer
por: Jung, Ji-Jung, et al.
Publicado: (2023)

Pathologically confirmed pancreatic hamartoma after surgical resection with an aldosterone-producing adrenal tumor: a case report
por: Kim, Jae Han, et al.
Publicado: (2023)

Effect of Homogenization Pressure on Plasmin Activity and Mechanical Stress-Induced Fat Aggregation of Commercially Sterilized Ultra High Temperature Milk during Storage
por: Kim, Sun-Chul, et al.
Publicado: (2020)

Programmed Death Ligand 1 Immunohistochemistry in Triple-Negative Breast Cancer: Evaluation of Inter-Pathologist Concordance and Inter-Assay Variability
por: Ahn, Soomin, et al.
Publicado: (2021)

Evaluation of the Survival Benefit of Different Chemotherapy Regimens in Patients with T1-2N0 Triple-Negative Breast Cancer
por: Kim, Hyun-Ah, et al.
Publicado: (2015)

Factors influencing serum progesterone level on triggering day in stimulated in vitro fertilization cycles
por: Park, Ju Hee, et al.
Publicado: (2015)

Estrogen Rather Than Progesterone Cause Constipation in Both Female and Male Mice
por: Oh, Ji-Eun, et al.
Publicado: (2013)

Feasibility of Sentinel Lymph Node Biopsy in Breast Cancer Patients with Initial Axillary Lymph Node Metastasis after Primary Systemic Therapy
por: Kang, Eunyoung, et al.
Publicado: (2011)

MicroRNA-222 Expression as a Predictive Marker for Tumor Progression in Hormone Receptor-Positive Breast Cancer
por: Han, Song-Hee, et al.
Publicado: (2017)

Level of Combined Estrogen and Progesterone Receptor Expression Determines the Eligibility for Adjuvant Endocrine Therapy in Breast Cancer Patients
por: Ahn, Jee Hyun, et al.
Publicado: (2021)

Cumulative live birth rate after up to three consecutive embryo transfer cycles in women with poor ovarian response
por: Kim, Se Jeong, et al.
Publicado: (2020)

Potential Prognostic Value of Histone Deacetylase 6 and Acetylated Heat-Shock Protein 90 in Early-Stage Breast Cancer
por: Park, Younghee, et al.
Publicado: (2015)

Conversion Surgery in Metastatic Gastric Cancer and Cancer Dormancy as a Prognostic Biomarker
por: Choe, Hun Jee, et al.
Publicado: (2019)

A comparison of Ki-67 counting methods in luminal Breast Cancer: The Average Method vs. the Hot Spot Method
por: Jang, Min Hye, et al.
Publicado: (2017)

B7-H3 expression is associated with high PD-L1 expression in clear cell renal cell carcinoma and predicts poor prognosis
por: Lee, Jung Hee, et al.
Publicado: (2023)

Conversion of an oral to nasal intubation in difficult nasal anatomy patients: two case reports
por: Kim, Dong Won, et al.
Publicado: (2021)

Diversity index as a novel prognostic factor in breast cancer
por: Chung, Yul Ri, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_k5qdts78knbjof0jpjvpjoaccq